DE69230000T2 - Verfahren und testsatz zur messung von endogenen zytokinen - Google Patents

Verfahren und testsatz zur messung von endogenen zytokinen

Info

Publication number
DE69230000T2
DE69230000T2 DE69230000T DE69230000T DE69230000T2 DE 69230000 T2 DE69230000 T2 DE 69230000T2 DE 69230000 T DE69230000 T DE 69230000T DE 69230000 T DE69230000 T DE 69230000T DE 69230000 T2 DE69230000 T2 DE 69230000T2
Authority
DE
Germany
Prior art keywords
cytokines
measuring
present
cytokins
endogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69230000T
Other languages
English (en)
Other versions
DE69230000D1 (de
Inventor
Lawrence Tamarkin
Giulio Paciotti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytimmune Sciences Inc
Original Assignee
Cytimmune Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytimmune Sciences Inc filed Critical Cytimmune Sciences Inc
Publication of DE69230000D1 publication Critical patent/DE69230000D1/de
Application granted granted Critical
Publication of DE69230000T2 publication Critical patent/DE69230000T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69230000T 1991-07-19 1992-07-17 Verfahren und testsatz zur messung von endogenen zytokinen Expired - Fee Related DE69230000T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73286791A 1991-07-19 1991-07-19
US85510992A 1992-03-20 1992-03-20
PCT/US1992/005981 WO1993002359A1 (en) 1991-07-19 1992-07-17 Method and kit for measuring endogenous cytokines

Publications (2)

Publication Number Publication Date
DE69230000D1 DE69230000D1 (de) 1999-10-21
DE69230000T2 true DE69230000T2 (de) 2000-05-11

Family

ID=27112472

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230000T Expired - Fee Related DE69230000T2 (de) 1991-07-19 1992-07-17 Verfahren und testsatz zur messung von endogenen zytokinen

Country Status (8)

Country Link
US (1) US5587294A (de)
EP (1) EP0598758B1 (de)
JP (1) JP3183666B2 (de)
AT (1) ATE184703T1 (de)
AU (1) AU2392692A (de)
CA (1) CA2113823A1 (de)
DE (1) DE69230000T2 (de)
WO (1) WO1993002359A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965379A (en) * 1991-07-19 1999-10-12 Cytimmune Sciences Inc. Method for measuring endogenous cytokines
ES2401121T3 (es) * 1996-10-04 2013-04-17 Veri-Q Inc. Dispositivos de recolección de muestras y métodos que utilizan marcadores y el uso de dichos marcadores como controles en la validación de una muestra, evaluación y/o certificación de laboratorio
US6673621B1 (en) * 1996-10-04 2004-01-06 Intronn Llc Sample collection devices and methods using markers and the use of such markers as controls in sample validation, laboratory evaluation and/or accreditation
US6824986B1 (en) 1997-10-06 2004-11-30 University Of Cincinnati Methods for measuring in vivo cytokine production
WO2002033418A1 (en) * 2000-10-17 2002-04-25 Besst-Test Aps Assay for directly detecting a biological cell in a body fluid sample
WO2002033408A1 (en) * 2000-10-17 2002-04-25 Besst-Test Aps Assay for directly detecting an inflammatory indicator in a body fluid sample
DK1340086T3 (da) * 2000-10-17 2008-12-01 Besst Test Aps Assay til direkte detektion af en RS-virusrelateret biologisk celle i en legemsvæskepröve
EP1354206A2 (de) * 2000-12-13 2003-10-22 Bio-Rad Laboratories, Inc. Standard-verdünnungsmittel für multiplex-bestimmungen
WO2004112691A2 (en) * 2003-05-19 2004-12-29 Intermune, Inc. Interferon gamma therapies for idiopathic pulmonary fibrosis
WO2005029091A2 (en) 2003-09-15 2005-03-31 Oklahoma Medical Research Foundation Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases
US20060084184A1 (en) * 2004-10-19 2006-04-20 Renovar Incorporated Reagents for urine-based immunological assays
US20070150204A1 (en) * 2005-12-27 2007-06-28 Benjamin Wiegand Methods for recommending a program to improve or maintain pro-inflammatory immune health
US20070150203A1 (en) * 2005-12-27 2007-06-28 Benjamin Wiegand A kit for assessing the pro-inflammatory immune health of an individual
US20070150202A1 (en) * 2005-12-27 2007-06-28 Benjamin Wiegand A method for assessing the efficacy of a program to improve or maitain the pro-inflammatory immune health
US20070150205A1 (en) * 2005-12-27 2007-06-28 Benjamin Wiegand Methods for assessing the pro-inflammatory immune health of an individual
US20070150310A1 (en) * 2005-12-27 2007-06-28 Benjamin Wiegand A method of motivating an individual to improve lifestyle factors
DK2996808T3 (da) * 2013-05-14 2020-02-24 Fibrotx Oue Lateral flow assay-indretning
WO2020241809A1 (ja) * 2019-05-31 2020-12-03 日本たばこ産業株式会社 幸福感の評価方法及び幸福感を評価するためのデータ取得方法
US20230314424A1 (en) * 2020-08-17 2023-10-05 Rjs Mediagnostix Fluid testing device

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31006E (en) * 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other
US3654090A (en) * 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
NL154598B (nl) * 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) * 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
USRE32696E (en) * 1975-09-04 1988-06-14 Akzona Incorporated Enzymatic immunological method for determination of antigens and antibodies
US4016043A (en) * 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4020151A (en) * 1976-02-17 1977-04-26 International Diagnostic Technology, Inc. Method for quantitation of antigens or antibodies on a solid surface
JPS604422B2 (ja) * 1976-10-07 1985-02-04 持田製薬株式会社 抗原の定量方法
US4271140A (en) * 1978-01-23 1981-06-02 Baxter Travenol Laboratories, Inc. Method and composition for double receptor, specific binding assays
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
AU8594382A (en) * 1981-08-05 1983-02-10 F. Hoffmann-La Roche Ag Immunoassay using biotin-avidin-enzyme complex
EP0105714B1 (de) * 1982-09-29 1988-07-27 Serono Diagnostics Limited Immunoassay auf Antigene
US4496654A (en) * 1983-04-08 1985-01-29 Quidel Detection of HCG with solid phase support having avidin coating
US4798207A (en) * 1983-05-09 1989-01-17 Wade Stephen E Device for enabling time-integrated measurement of substances in biological fluids
US4594326A (en) * 1983-05-09 1986-06-10 Wade Stephen E Time-integrated measurement for determining substances in biological fluids
JPS62162963A (ja) * 1986-01-10 1987-07-18 Sadao Shiosaka 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法
ZA872784B (en) * 1986-05-01 1987-10-16 Immunex Corporation Detection of inflammation and novel antibodies therefor
US4863726A (en) * 1987-05-29 1989-09-05 Cetus Corporation Combination therapy using immunotoxins with interleukin-2

Also Published As

Publication number Publication date
JPH06509418A (ja) 1994-10-20
EP0598758A1 (de) 1994-06-01
EP0598758A4 (de) 1995-02-01
WO1993002359A1 (en) 1993-02-04
DE69230000D1 (de) 1999-10-21
ATE184703T1 (de) 1999-10-15
AU2392692A (en) 1993-02-23
US5587294A (en) 1996-12-24
JP3183666B2 (ja) 2001-07-09
EP0598758B1 (de) 1999-09-15
CA2113823A1 (en) 1993-02-04

Similar Documents

Publication Publication Date Title
DE69230000T2 (de) Verfahren und testsatz zur messung von endogenen zytokinen
DE69016428D1 (de) Vorrichtung und verfahren zur bestimmung eines bestandteiles in einer flüssigkeitsprobe.
ATE268477T1 (de) Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
DE69333144D1 (de) Verfahren zur Identifizierung von Hemmstoffe der Produktion des beta-Amyloidpeptids
ATE355865T1 (de) Messvorrichtung und -verfahren zur bestimmung von parametern medizinischer flüssigkeiten
DE69418546D1 (de) Vorrichtung und Verfahren zur Messung der Konzentration von Glukose mittels Lichtstreuung
NO954897L (no) Fremgangsmåte for å bestemme et individs inflammasjonsindeks fra hele blodfibrinogen og hematokrit eller hemoglobinmålinger
ATE100150T1 (de) Verfahren zur bestimmung von physiologisch wirksamen substanzen.
ATE255726T1 (de) Verfahren zur vorhersage von frühgeburten
DE59207599D1 (de) Vorrichtung und Verfahren zur Ermittlung des Herzzeitvolumens
DE3767042D1 (de) Messvorrichtung zur intrakardialen erfassung der blutsauerstoffsaettigung.
ATE122467T1 (de) Verfahren zur detektion von knochen- und anderen bindegewebeerkrankungen bei menschen und tieren.
ATE45482T1 (de) Messwertaufnehmer zur gleichzeitigen messung verschiedener physiologischer groessen.
EP0329458A3 (de) Verfahren und Gerät zur Messung von Analyten
ATE76761T1 (de) Vorrichtung zur kontinuierlichen oder diskontinuierlichen verabreichung von insulin in den menschlichen koerper.
DE3875826T2 (de) Methode, vorrichtung und testsatz zur messung der aktivitaet eines gewebeplasminogenaktivators.
DE3750745D1 (de) Verfahren und Gerät zur Messung des systolischen Blutdrucks.
DE3883145T2 (de) Verfahren zur Messung von humanen Insulin.
ATE291874T1 (de) Verfahren zur messung des arteriolendrucks
ATE64470T1 (de) Verfahren und zusammensetzungen zur bestimmung von heparin.
ATE195182T1 (de) Überwachung von patienten mit lungenkrebs durch messung von nca 50/90 im blut
SU1718116A1 (ru) Способ измерени кальци сыворотки крови
DE68918147T2 (de) Verfahren und Vorrichtung zur Messung der Viskosität von frischem Säugetierblut.
ATE82396T1 (de) Methode, vorrichtung und testsatz zur messung der aktivitaet eines gewebeplasminogenaktivators.
ATE295114T1 (de) Gerät und verfahren zur messung von biologischen strukturen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee